In the Media

Dr. Francis Collins, director of the NIH, spotlights new research by Galit Alter of the Ragon Institute of MIT and Harvard. Alter and her colleagues found that “the antibody responses in kids and adults with mild Covid-19 are quite similar. However, the complications seen in kids with MIS-C and adults with severe Covid-19 appear to be driven by two distinctly different types of antibodies involved in different aspects of the immune response.”